Program of vascular evaluation under glucose control by DPP-4 inhibitor.

Trial Profile

Program of vascular evaluation under glucose control by DPP-4 inhibitor.

Completed
Phase of Trial: Phase III

Latest Information Update: 15 May 2017

At a glance

  • Drugs Sitagliptin (Primary) ; Antihyperglycaemics
  • Indications Atherosclerosis
  • Focus Therapeutic Use
  • Acronyms PROLOGUE
  • Most Recent Events

    • 15 May 2017 Status changed from active, no longer recruiting to completed.
    • 16 Nov 2016 Results of sub analysis assessing effect of sitagliptin on echocardiographic systolic and diastolic parameters and N-terminal pro brain natriuretic peptide, presented at the 89th Annual Scientific Sessions of the American Heart Association
    • 02 Nov 2012 Planned number of patients changed from 1200 to 500 as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top